Indo US Bio-Tech FY26: Profit Falls 19% While Inventory Swells to Nearly a Full Year of Sales

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1 — At a Glance

Here is a seed company that grew sales from ₹24 crore to ₹110 crore over ten years, and in its most recent year did something that deserves a second look: revenue rose to ₹110.44 crore, yet net profit fell to ₹13.12 crore from ₹16.27 crore the year before — a 19% drop. Operating cash flow, positive for four straight years, swung to an outflow of ₹12.58 crore. Borrowings more than doubled, from ₹14.84 crore to ₹37.03 crore. And inventory closed the year at ₹99.05 crore — against annual sales of ₹110.44 crore.

That last number is the one worth sitting with. A seed processor is now holding stock worth nearly its entire year’s revenue, and it borrowed to do it.

Around the same period, the statutory auditor resigned mid-term, a new one was appointed subject to shareholder approval, and disclosed income-tax demands sit under dispute across seven assessment years. None of these are conclusions. They are line items.

The question this year poses: when a growing business stops generating cash, where did the money go — and the balance sheet answers before the narrative does.

2 — Introduction

Indo US Bio-Tech Ltd, incorporated in 2004 and based in Ahmedabad, produces and processes commercial and vegetable seeds. It breeds, produces, processes, packs, and markets hybrid and open-pollinated varieties, working through seed-production agreements with growers who are reimbursed for cultivation expenses.

The company holds an ISO 9001:2015 certificate, is a member of the National Seed Association of India, and carries DSIR recognition for an in-house R&D unit. In September 2024 it migrated from the BSE SME platform to the BSE and NSE main boards. A 1:1 bonus issue was recommended in August 2023, which is why the equity share count doubled to roughly 2.01 crore shares in FY24 — a detail that matters when reading per-share figures later.

The last twelve months carried several corporate events: audited FY26 results approved on 29 May 2026, a statutory-auditor change in June, and a postal ballot in July covering an independent director’s regularisation and the new auditor’s appointment. Each is recorded in its place below.

3 — Business Model: WTF Do They Even Do?

They sell seeds. A lot of kinds of seeds.

The catalogue is genuinely wide: vegetable seeds (tomato, okra, brinjal, gourds of at least four varieties, carrot, onion, watermelon), oil seeds (castor, groundnut, sesamum, mustard, soybean), spices (cumin, isabgul), pulses, cereals, and a line of Indo US-branded hybrid cotton running from the 918 to the 999. The model is R&D-led breeding at one end and a marketing network at the other, with growers doing the actual cultivation on leased land in between.

That leased-land arrangement is the structural quirk. The company owns no land; factory buildings and cold storage sit on long-term leasehold properties with no lease-rental obligations, per the auditor’s report. It compensates farmers per rate agreements, then processes and sells what comes back.

FY23 disclosures put production sales at about 86% of revenue and traded goods at 14%, with agricultural activities forming roughly 89% of segment revenue. Exports have reached the USA, Palestine, Kuwait, Cameroon, Sri Lanka, and Mauritius.

It is an asset-light frame on paper — no owned land, leased premises — which makes it all the more striking that so much capital has ended up parked in one place. A seed business is seasonal by nature; inventory and cultivation cycles swing hard. But the model’s whole promise is that seeds turn into sales. This year, a great many of them stayed seeds.

Does an asset-light lease model still count as asset-light when ₹99 crore of working capital is tied up in stock?

4 — Financials Overview

Figures are standalone, in ₹ crore.

The March quarter shows revenue down 22% against the same quarter last year, and net profit down 46%. Sequentially, revenue rose 14% off the December quarter while profit fell — the March quarter’s operating margin was 12.4%, the softest of the recent set, and the tax charge landed at 17.2% versus low-single-digit rates in prior quarters, which compressed the bottom line further.

The board approved the audited FY26 results on